tradingkey.logo
tradingkey.logo
Search

Amneal Announces BLA Submission Of Biosimilar Candidate To Xolair® (Omalizumab)

ReutersSep 26, 2025 12:05 PM
facebooktwitterlinkedin
View all comments0

- Amneal Pharmaceuticals Inc AMRX.O:

  • AMNEAL ANNOUNCES BLA SUBMISSION OF BIOSIMILAR CANDIDATE TO XOLAIR® (OMALIZUMAB)

  • AMNEAL PHARMACEUTICALS INC - CO EXPECTS $22.5 MILLION RESEARCH AND DEVELOPMENT CHARGE IN QTRLY 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI